<SEC-DOCUMENT>0001104659-23-110237-index.html : 20231020 <SEC-HEADER>0001104659-23-110237.hdr.sgml : 20231020 <ACCEPTANCE-DATETIME>20231019202216 ACCESSION NUMBER: 0001104659-23-110237 CONFORMED SUBMISSION TYPE: S-8 POS PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231020 DATE AS OF CHANGE: 20231019 EFFECTIVENESS DATE: 20231020 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 POS SEC ACT: 1933 Act SEC FILE NUMBER: 333-240178 FILM NUMBER: 231335811 BUSINESS ADDRESS: STREET 1: 25-28 NORTH WALL QUAY CITY: DUBLIN STATE: L2 ZIP: D01 H104 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 414 COMMERCE DRIVE STREET 2: STE 120 CITY: FORT WASHINGTON STATE: PA ZIP: 19034 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 POS <SEQUENCE>1 <FILENAME>tm2328826d6_s8pos.htm <DESCRIPTION>S-8 POS <TEXT> Document 1 - file: tm2328826d6_s8pos.htm
</DOCUMENT> </SEC-DOCUMENT>